Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENABLE 2: ePGT121v1-LS and VRC07-523-LS in Infants Living With HIV
NCT07655141Phase 2Not yet recruiting
- Sponsor
- Hospital Universitario 12 de Octubre
- Start
- Jan 2027
- Primary completion
- Jul 2029
01
Overview
A Phase 2 trial of ePGT121v1-LS, VRC07-523LS in human immunodeficiency virus infection (HIV), sponsored by Hospital Universitario 12 de Octubre. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
ePGT121v1-LSVRC07-523LS
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07655141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07655141.